体外循环回路输送一氧化氮对成人心脏术后氧合的影响:NOCARD随机对照试验
一氧化氮组在心脏重症监护室入院时低氧血症发生率显著低于对照组(47.1% vs 68.1%,P=0.043),基线低氧血症患者获益更明显(61.1% vs 93.8%,P=0.042),低心排综合征和急性肾损伤无显著差异。
要点
- 体外循环回路给40 ppm一氧化氮可降低心脏术后早期低氧血症发生率
- 基线低氧血症患者获益更显著,PaO2/FiO2比值在所有时间点更高
- 低心排综合征和急性肾损伤发生率无显著差异
核心结论
- 基线低氧血症患者接受一氧化氮后低氧血症发生率更低且PaO2/FiO2比值更高
- 术后肺部并发症及总体结局无显著差异
研究设计与样本
- 前瞻性、单中心、双盲、随机对照试验
主要发现
- 一氧化氮组心脏重症监护室入院时低氧血症发生率显著低于对照组(47.1% vs 68.1%,P=0.043)
- 基线低氧血症患者中一氧化氮组低氧血症发生率显著更低(61.1% vs 93.8%,P=0.042),PaO2/FiO2比值在所有时间点更高(F(1,30)=6.08,P=0.019)
- 无基线低氧血症患者中未观察到该获益
- 低心排综合征和急性肾损伤发生率无显著差异,未观察到明显安全性问题及毒性高铁血红蛋白水平
关键数值与推荐
- 干预组经体外循环回路给予40 ppm一氧化氮,对照组不给一氧化氮
- 主要结局为术后24小时内低氧血症发生率,定义为PaO2/FiO2比值小于300
- 次要结局为术后72小时内低心排综合征和急性肾损伤发生率
临床怎么用
- 对基线存在低氧血症的成人心脏手术患者,可考虑经体外循环回路给予40 ppm一氧化氮以改善术后早期氧合
- 对无基线低氧血症患者,该干预的获益未获证实
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cardiac surgery involving cardiopulmonary bypass induces a significant systemic inflammatory response, contributing to various postoperative complications, including pulmonary dysfunction, myocardial and kidney injuries. OBJECTIVE: To investigate the effect of Nitric Oxide delivery via the cardiopulmonary bypass circuit on various postoperative outcomes. DESIGN: A prospective, single-centre, double-blinded, randomised controlled trial. SETTING: Rabin Medical Centre, Beilinson Hospital, Israel. PATIENTS: Adult patients scheduled for elective cardiac surgery were randomly allocated to one of the study groups. INTERVENTIONS: For the treatment group, 40 ppm of nitric oxide was delivered via the cardiopulmonary bypass circuit. For the control group, nitric oxide was not delivered. OUTCOME MEASURES: The primary outcome was the incidence of hypoxaemia, defined as a p a O2 /FiO 2 ratio less than 300 within 24 h postoperatively. The secondary outcomes were the incidences of low cardiac output syndrome and acute kidney injury within 72 h postoperatively. RESULTS: Ninety-eight patients were included in the final analysis, with 47 patients allocated to the control group and 51 to the Nitric Oxide group. The Nitric Oxide group exhibited significantly lower hypoxaemia rates at admission to the cardiothoracic intensive care unit (47.1 vs. 68.1%), P = 0.043. This effect, however, varied in patients with or without baseline hypoxaemia. Patients with baseline hypoxaemia who received nitric oxide exhibited significantly lower hypoxaemia rates (61.1 vs. 93.8%), P = 0.042, and higher p a O2 /FiO 2 ratios at all time points, F (1,30) = 6.08, P = 0.019. Conversely, this benefit was not observed in patients without baseline hypoxaemia. No significant differences were observed in the incidence of low cardiac output syndrome or acute kidney injury. No substantial safety concerns were noted, and toxic methaemoglobin levels were not observed. CONCLUSIONS: Patients with baseline hypoxaemia undergoing cardiac surgery and receiving nitric oxide exhibited lower hypoxaemia rates and higher p a O2 /FiO 2 ratios. No significant differences were found regarding postoperative pulmonary complications and overall outcomes. TRIAL REGISTRATION: NCT04807413.
引用
- Azem K, Novakovsky D, Krasulya B, et al. Effect of nitric oxide delivery via cardiopulmonary bypass circuit on postoperative oxygenation in adults undergoing cardiac surgery (NOCARD trial): a randomised controlled trial. Eur J Anaesthesiol. 2024. PMID: 39037709. doi:10.1097/EJA.0000000000002022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。